Skip to content

Drug interactions

Clarithromycin + Liposomal doxorubicin

Severity: Moderate

Clarithromycin and Liposomal doxorubicin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Clarithromycin inhibits CYP3A4 and P-glycoprotein and may raise doxorubicin exposure. This could increase myelosuppression, mucositis and cardiotoxicity. Clarithromycin also prolongs the QT interval, which adds to cardiac concern.

What this interaction means in plain words

Clarithromycin and Liposomal doxorubicin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Clarithromycin belongs to Anti Bacterial; Liposomal doxorubicin belongs to Oncology.

Evidence level: Low

Why it happens

Clarithromycin inhibits CYP3A4 and P-glycoprotein, reducing doxorubicin clearance.

What to do

Use an alternative antibiotic such as azithromycin if clinically suitable. Otherwise monitor blood counts, ECG and signs of anthracycline toxicity.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Clarithromycin and Liposomal doxorubicin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Clarithromycin with Liposomal doxorubicin?

MediHelp rates the interaction as moderate. Clarithromycin and Liposomal doxorubicin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Clarithromycin inhibits CYP3A4 and P-glycoprotein and may raise doxorubicin exposure. This could increase myelosuppression, mucositis and cardiotoxicity. Clarithromycin also prolongs the QT interval, which adds to cardiac concern.

How serious is the interaction between Clarithromycin and Liposomal doxorubicin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Use an alternative antibiotic such as azithromycin if clinically suitable. Otherwise monitor blood counts, ECG and signs of anthracycline toxicity.

What other medicines interact with Liposomal doxorubicin?

MediHelp also lists interactions of Liposomal doxorubicin with, for example, Dengue vaccine, Belatacept, Cyclosporine. The full list is on the Liposomal doxorubicin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in